EFFECT OF FTY720 ON THE SET-PP2A COMPLEX IN ACUTE MYELOID LEUKEMIA. SET BINDING DRUGS HAVE ANTAGONISTIC ACTIVITY
EHA Library, Raffaella Pippa, 55653
RESPONSE TO LISINOPRIL IN PATIENTS WITH SICKLE CELL ANEMIA AND PROTEINURIA
EHA Library, Aamer Aleem, 55651
IRON-INDUCED EPIGENETIC ABNORMALITY OF MOUSE BONE MARROW THROUGH ABERRANT ACTIVATION OF ACONITASE AND ISOCITRATE DEHYDROGENASE WITHOUT GENE MUTATION: ANALYSIS BY HIGH THROUGHPUT SEQUENCER AND GC-MS.
EHA Library, Masayo Yamamoto, 55649
ACCELERATION OF BCR-ABL+ LEUKEMIA INDUCED BY DELETION OF JAK2
EHA Library, Eva Grundschober, 55647
THE NOTCH PATHWAY IS RECURRENTLY MUTATED IN DIFFUSE LARGE B CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C VIRUS INFECTION
EHA Library, Luca Arcaini, 55646
The Perspective from Horizon 2020
EHA Library, Hele Everaus, 55637
The Perspective from Personalized Medicine
EHA Library, Mark Lawler, 55636
The Roadmap for Research in Hematology in Europe
EHA Library, Andreas Engert, 55635
EHA19 Chair comments: The Future of Hematological Research in Europe
EHA Library, Ulrich Jäger, 55634
A single oncogenic Enhancer-Rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia
EHA Library, Stefan Gröschel, 55628
The KRÜPEL-Like factor 2 (KLF-2) Transcription factor is recurrently mutated in splenic marginal zone Lymphoma
EHA Library, Davide Rossi, 55631
Randomized comparision of Ibrutinib versus Ofatumumab in previously treated chronic Lymphocytic Leukemia / Small Lymphocytic lymphoma: Results from the phase III PCYC-1112 Resonate (TM) Trial
EHA Library, Peter Hillmen, 55630
Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangiectasia: results of a prospective phase II clinical trail
EHA Library, Rosangela Invernizzi, 55629
EHA19 Jean Bernard Lifetime Achievement Award
EHA Library, Freda Stevenson, 55627
EHA19 Presidential Symposium - Best Abstracts: Introduction
EHA Library, Pieter Sonneveld, 55626
EHA19 Jean Bernard Lifetime Achievement Award: Introduction
EHA Library, Christine Chomienne, 55625
First interim analysis of a pan-european stop trial using standardized molecular criteria: results of the Euro-Ski trial
EHA Library, Susanne Saussele, 57766
Kids a-long: safety, efficacy, and pharmacokinetics of long-acting recombinant factor VIII FC fusion protein (RFVIIIFC) in previously-treated paediatric subjects with Haemophilia A
EHA Library, Beatrice Nolan, 57763
Ruxolitinib proves superior to best available therapy in a prospective, randomized, phase 3 study (response) in patients with Polycythemia vera resistant to or intolerant of Hydroxyurea
EHA Library, Alessandro M. Vannucchi, 57762
A phase I study of AG-221, a first in class, potent inhibitor of the IDH2-MUTANT PROTEIN, in patients with IDH2 MUTANT POSITIVE ADVANCED HEMATOLOGIC MALIGNANCIES
EHA Library, Stéphane De Botton, 57760
EHA19 EHA-ASH Joint Symposium: Access to Medicines and Fair Pricing: the Cost of Innovative Drugs
EHA Library, Jean-Luc Harousseau, 55623
EHA19 Chair comments: EHA-ASH Joint Symposium
EHA Library, Christine Chomienne and Linda Burns, 57615
Treatment of thrombosis in cancer patients
EHA Library, Sabine Eichinger, 55614
MM: From clone to target to therapy
EHA Library, Keith Stewart, 55615
Sexuality, fertility and family planning in hematological diseases
EHA Library, Mairéad Ní Chonghaile, 55610
Old people's diseases in young patients with chronic rare anemias
EHA Library, Michael Michael, 55611
EHA19 Chair comments: Part 2 - The challenges of young patients with old people's diseases
EHA Library, Androulla Eleftheriou, 57769
Panel discussion - Part 1 - Generics in Hematology: The doctors' and patients' perspective
EHA Library, Faculty / Presenters, 57768
The patients' perspective
EHA Library, Sarunas Narbutas, 55608
The hematologists' clinical perspective
EHA Library, Ivana Urosevic, 56795
EHA19 Chair comments: Part 1 - Generics in Hematology: The doctors' and patients' perspective
EHA Library, Jan Geissler, 55604
EHA19 Chair comments: Part 1 - Generics in Hematology: The doctors' and patients' perspective
EHA Library, Androulla Eleftheriou, 55605
Drug quality in generics, substandard drugs, copies – the pharmacologist perspective
EHA Library, Atholl Johnston, 55606
ASSESSMENT OF INFECTION EVENTS IN AZACITIDINE (AZA) TREATMENT FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML). A SINGLE CENTRE EXPERIENCE.
EHA Library, PILAR ROMERO FERNANDEZ, 54028
AZACITIDINE AND INTENSIVE CHEMOTHERAPY IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: A META-ANALYSIS
EHA Library, SuJun Gao, 53628
INFECTIONS IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME ON TREATMENT WITH AZACYTIDINE: EXPERIENCE OF A SINGLE CENTER.
EHA Library, Sunil Lakhwani, 54027
ANALYSIS OF PNEUMONIA IN ACUTE LEUKEMIA: A PROSPECTIVE STUDY BY THE 'RETE EMATOLOGICA LOMBARDA' (REL)
EHA Library, Valentina Mancini, 54026
THE CLINICAL SPECTRUM AND OUTCOMES OF HUMAN HERPESVIRUS 6-RELATED INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Livia Hegerova, 54025
PHASE IB STUDY OF PF-04449913, A HEDGEHOG (HH) INHIBITOR, IN COMBINATION WITH LOW-DOSE CYTARABINE OR INTENSIVE CHEMOTHERAPY, IN ACUTE MYELOID LEUKEMIA (AML) OR HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
EHA Library, Ashleigh O'Connell, 53625
LOW DOSE GEMTUZUMAB OZOGAMICIN PLUS FLAI AS INDUCTION THERAPY IN CD33-POSITIVE AML. DEFINITIVE RESULTS AND LONG TERM OUTCOME OF A PHASE III MULTICENTER PROSPECTIVE CLINICAL TRIAL (NCT.00909168).
EHA Library, Anna CANDONI, 53624
CLINICAL CHARACTERISTICS AND OUTCOMES OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTS
EHA Library, Desire Gijima, 54024
ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY
EHA Library, Adolfo De La Fuente, 53623
IMPACT OF NOSOCOMIAL VIRAL INFECTION IN CHILDREN UNDERGOING INTENSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION FOR HEMATOLOGIC OR MALIGNANT DISEASE
EHA Library, Hiroshi Yagasaki, 54023
TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION DOESN'T INCREASE THE RISK OF SYMPTOMATIC CYTOMEGALOVIRUS REACTIVATION IN MYELOMA PATIENTS IN THE ERA OF NOVEL AGENTS: A SINGLE INSTITUTION STUDY
EHA Library, Francesco Marchesi, 54022
TREATMENT WITH RADIATION, CHEMOTHERAPY, OR BOTH DEMONSTRATES SIMILAR OUTCOMES IN PATIENTS WITH ISOLATED MYELOID SARCOMA THAT MAY NOT BE DIFFERENT THAN DE NOVO ACUTE MYELOID LEUKEMIA
EHA Library, Faye Feller, 53622
NOVEL FUNCTION FOR THE RNA BINDING PROTEINS RBM38 AND DND1 IN AML CELL DIFFERENTIATION
EHA Library, Julian Wampfler, 53621
A RETROSPECTIVE ANALYSIS OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH MALIGNANT LYMPHOMAS WHO HAVE NOT RECEIVED HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Kazuya Sato, 54021
LOW MST1 HIPPO KINASE EXPRESSION CONTRIBUTES TO DIFFERENTIATION DEFICIENCY IN AML CELLS
EHA Library, Julian Wampfler, 53620
SAFE RITUXIMAB ADMINISTRATION TO NHL PATIENTS WITH CONCOMITANT HBV ACTIVE INFECTION: THE RISK OF HBV REACTIVATION SHOULD NOT PREVENT US TO DELIVER OPTIMAL TREATMENT
EHA Library, Vittorio Ruggero Zilioli, 54020
PREVALENCE, CHARACTERISTICS AND MANAGEMENT OF OCCULT HEPATITIS B VIRUS INFECTION (OBI) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS. MONOCENTRIC EXPERIENCE.
EHA Library, Luca Laurenti, 54019
THE IMPACT OF HEPATITIS B VIRUS (HBV) INFECTION ON PROGNOSIS OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND THE OCCURRENCE OF HEPATITIS FLARES AFTER WITHDRAWAL OF PROPHYLACTIC ANTIVIRAL TREATMENT
EHA Library, Man Fai Law, 54018
THE CATS (FAM64A) PROTEIN IS IMPORTANT FOR CLONOGENICITY OF THE MONOCITIC LEUKEMIA CELL LINE U937
EHA Library, Isabella Barbutti, 53617
ROLE OF PROPHYLAXIS WITH LAMIVUDINE IN MAINTENANCE TREATMENT WITH RITUXIMAB IN NON HODGKIN LYMPHOMA CD20+
EHA Library, Claudio Cerchione, 54017
PURE RED CELL APLASIA IN PAEDIATRIC HIV
EHA Library, Rajendra Thejpal, 54016
ALTERATIONS IN MESENCHYMAL STROMAL PRECURSOR CELLS FROM THE BONE MARROW OF THE ACUTE MYELOID LEUKEMIA PATIENTS: NEWLY DIAGNOSED, AND BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Irina Shipounova, 53615
CHANGING OF PLATELET DERIVED MICROPARTICLES, SCUBE-1 AND IL-1? IN CHILDREN WITH DENGUE INFECTION
EHA Library, Darintr Sosothikul, 54015
MESENCHYMAL STEM CELLS (MSCS) OF AML PATIENTS HARBOR CHROMOSOMAL DEFECTS DISTINCT FROM THOSE OF LEUKEMIC CELLS.
EHA Library, Paolo Bernasconi, 53614
VARICELLA-ZOSTER VIRUS INFECTIONS IN IMMUNOCOMPROMISED PATIENTS; COMPARISON OF HEMATOLOGY – ONCOLOGY PATIENTS AND OTHER CHRONIC DISEASES
EHA Library, Asim Yoruk, 54014
LEUKEMIC STEM CELLS OF ACUTE MYELOID LEUKEMIA PATIENTS CARRYING NPM1 MUTATION ARE CANDIDATES FOR TARGETED IMMUNOTHERAPY
EHA Library, Jochen Greiner, 53613
SERIAL TRANSPLANTATION AND IN VIVO IMAGING OF PATIENT-DERIVED XENOGRAFTS: AN ADVANCED PRECLINICAL MODEL TO STUDY DIVERSE GENETIC AML SUBGROUPS IN MICE
EHA Library, Binje Vick, 53612
THE IKAROS 6 ISOFORM COOPERATES WITH BCR-ABL1 TO INDUCE HUMAN ACUTE MYELOID LEUKEMIA IN XENOGRAFTS
EHA Library, Alexandre , 53611
CHARACTERIZATION OF RARE ?LPHA-GLOBIN GENE MUTATIONS IN THAILAND
EHA Library, Noppacharn Uaprasert, 54011
NON-TRANSFERRIN BOUND IRON REVISITED: NOW THAT ITS POTENTIAL TOXICITY IS ESTABLISHED, HOW CAN ITS MEASUREMENT HELP TO GUIDE CHELATION
EHA Library, Vasilios Berdoukas, 54010
THE MYB-GATA1 FUSION IN THE CONTEXT OF LOW GATA1 EXPRESSION FAVOURS THE BASOPHILIC DIFFERENTIATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS.
EHA Library, Eric Lippert, 53610
OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: 24-MONTH FOLLOW-UP
EHA Library, Bulent Antmen, 54009
PITUITARY ABNORMALITIES IN SHORT ADOLESCENTS AND YOUNG ADULTS WITH SICKLE-CELL DISEASE (SCD) AND RECURRENT VASO-OCCLUSIVE CRISIS
EHA Library, Ashraf Soliman, 54008
GROWTH DIFFERENTIATION FACTOR-15 IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE: RELATION TO HEMOLYSIS, IRON OVERLOAD AND VASCULAR COMPLICATIONS
EHA Library, azza tantawy, 54007
POTENT COOPERATION BETWEEN THE NUP98-NSD1 FUSION AND THE FLT3-ITD MUTATION IN ACUTE MYELOID LEUKAEMIA INDUCTION
EHA Library, Angeliki Thanasopoulou, 53607
SOLUBLE FMS-LIKE TYROSINE KINASE-1 IN YOUNG PATIENTS WITH SICKLE CELL DISEASE: RELATION TO HEMOLYSIS-ASSOCIATED COMPLICATIONS
EHA Library, azza tantawy, 54006
THE CAMP RESPONSE ELEMENT BINDING PROTEIN (CREB) OVEREXPRESSION INDUCES MYELOID TRANSFORMATION IN ZEBRAFISH
EHA Library, Martina Pigazzi, 53606
OPHTHALMOLOGIC COMPLICATIONS IN A SICKLE CELL DISEASE COHORT WITH IN NORTH LEBANON
EHA Library, Adlette Inati, 54005
EARLY ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR OF RELAPSE OR SURVIVAL IN ACUTE MYELOID LEUKEMIA
EHA Library, Etsuko Yamazaki, 53539
HALOPLEX TARGET DNA ENRICHMENT ALLOWS INVESTIGATION OF COPY NUMBER AND MUTATIONAL STATUS OF KEY GENES IN ACUTE MYELOID LEUKAEMIA WITH NORMAL KARYOTYPE
EHA Library, Niccolò Bolli, 53604
IMPROVED COPY NUMBER VARIATION ESTIMATION FROM NEXT GENERATION SEQUENCING DATA REVEALS FOCAL GENETIC LESIONS SUCH AS MLL-PTD IN ACUTE MYELOID LEUKEMIA
EHA Library, Mathijs Sanders, 53603
VENOUS THROMBOEMBOLISM IN SICKLE CELL DISEASE: PREVALENCE AND PATIENT CHARACTERISTICS.
EHA Library, Victoria van Hamel Parsons, 54003
SUPER-SILAC BASED QUANTITATIVE PROTEOMICS IN ACUTE MYELOID LEUKEMIA
EHA Library, Elise Aasebø, 53538
IDENTIFICATION OF SOMATIC MUTATIONS OR FUSIONS BY RNA-SEQUENCING IN ACUTE MYELOID LEUKEMIA.
EHA Library, Ilaria Viganò, 53602
THE NUP98 FUSION PROTEINS ARE RECURRENT ABERRANCIES IN ACUTE MYELOID LEUKEMIA: A REPORT FROM THE AIEOP AML-2002 STUDY GROUP.
EHA Library, Martina Pigazzi, 53537
EFFECT OF SPLENECTOMY ON CARDIAC IRON AND FUNCTION IN DIFFERENT TRANSFUSION-DEPENDENT PATIENTS
EHA Library, Alessia Pepe, 54001
WHOLE EXOME SEQUENCING REVEALS CLONAL EVOLUTION PATTERNS AND DRIVER GENETIC ALTERATIONS OF RELAPSED PEDIATRIC AML
EHA Library, Kenichi Yoshida, 53601
FIBROSCAN FOR THE DETECTION OF LIVER FIBROSIS IN HAEMOGLOBINOPATHY PATIENTS REQUIRING CHRONIC TRANSFUSION THERAPY
EHA Library, Gasiorowski Robin, 54000
DNA METHYLATION PATTERNS AT DISEASE RELAPSE IN ACUTE MYELOID LEUKEMIA TARGET CONVERGENT ELEMENTS AND PATHWAYS DESPITE INTER-PATIENT HETEROGENEITY
EHA Library, Francine Garrett-Bakelman, 53600
NOVEL MUTATED GENES IN ACUTE PROMYELOCYTIC LEUKEMIA IDENTIFIED BY WHOLE-EXOME SEQUENCING
EHA Library, Mariam Ibañez, 53599
HIGH EXPRESSION LEVEL OF PRAME GENE IS FAVORABLE PROGNOSTIC FACTOR IN ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS
EHA Library, Vsevolod Misyurin, 53534
MAGNETIC RESONANCE IMAGING T2 AND R2* TECHNIQUES REFLECT RENAL HEMOSIDEROSIS IN PATIENTS WITH THALASSEMIA AND SICKLE-CELL DISEASE; CORRELATIONS WITH SERUM FERRITIN AND MARKERS OF HEMOLYSIS
EHA Library, Dimitrios Christoulas, 53998
GENOMIC ANALYSIS OF THE CLONAL ORIGIN AND EVOLUTION OF ACUTE PROMYELOCYTIC LEUKEMIA IN A UNIQUE PATIENT WITH A VERY LATE (17 YEARS) RELAPSE
EHA Library, Xiaolu Zhang, 53598
TWO-GROUP STUDY OF MEDIAL MICROSCOPY (MM) AS A ROBUST TOOL TO HARMONIZE AND STANDARDIZE HAEMATOLOGICAL DIAGNOSIS
EHA Library, Gina Zini, 53533
EXTRAMEDULLARY HEMATOPOIESIS (EMH) IS ASSOCIATED WITH A THALASSAEMIA INTERMEDIA-LIKE PATTERN OF MYOCARDIAL AND LIVER IRON LOADING IN REGULARLY POLYTRANSFUSED THALASSAEMIA PATIENTS
EHA Library, Alessia Pepe, 53997
TRAIL AND ITS RECEPTORS EXPRESSION ON LEUKEMIC CELLS OF PATIENTS WITH AML1-ETO POSITIVE ACUTE MYELOID LEUKEMIA
EHA Library, Li-Gen Liu, 53532
MOLECULAR CHARACTERIZATION OF THE MUTATIONS CAUSING G6PD DEFICIENCY AMONG EGYPTIAN CHILDREN WITH GENOTYPE - PHENOTYPE CORRELATION
EHA Library, Amira Adly, 53996
FANCONI ANEMIA AND DNA-REPAIR GENE VARIANTS IN THERAPY-RELATED MYELOID NEOPLASMS
EHA Library, Emiliano Fabiani, 53596
PRETREATMENT RISK SCORE FOR PREDICTION OF EARLY DEATH AFTER INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED MYELOID LEUKEMIA
EHA Library, Marijana Virijevic, 53531
SETBP1 MUTATIONS IN 106 PATIENTS WITH THERAPY-RELATED MYELOID NEOPLASMS
EHA Library, Emiliano Fabiani, 53595
MULTICENTER SURVEY ON OUTCOME OF AML REFRACTORY TO FIRST INDUCTION CHEMOTHERAPY IN THE LAST 4 YEARS (2010-2013).
EHA Library, Anna CANDONI, 53530
PDGF, PDGFR AND TGF GENE EXPRESSION PROFILE IN PATIENTS WITH BETA-THALASSEMIA AND SICKLE CELL DISEASE WITH AND WITHOUT PULMONARY HYPERTENSION.
EHA Library, Kapellos Gerasimos, 53994
SEQUENTIAL CARBOXY-TERMINAL PHOSPHORYLATION OF EVI1 UPON DNA DAMAGE
EHA Library, Marion Schneider, 53594
A RAPID BACTERIAL-BASED BIOLUMINESCENT ASSAY FOR IN-VITRO TESTING OF CHEMOTHERAPY SENSITIVITY IN ACUTE MYELOID LEUKAEMIA.
EHA Library, Elizabeth Anderson, 53529
HB CERVANTES, HB MARANON, HB LA MANCHA AND HB GOYA: DESCRIPTION OF FOUR NEW HEMOGLOBINOPHATIES
EHA Library, Felix De La Fuente Gonzalo, 53993
HAMP GENE MUTATION ASSOCIATED WITH JUVENILE HEMOCHROMATOSIS IN BRAZILIAN FAMILY
EHA Library, Paulo Santos, 53992
VALIDATION OF EUROPEAN LEUKEMIA NET (ELN) GUIDELINES FOR CYTOGENETICALLY NORMAL AML IN ASSOCIATION WITH NPM1 AND FLT3-ITD MUTATIONS: FURTHER STRATIFICATION FOCUSING ON WT1 EXPRESSION
EHA Library, JAE HO YOON, 53527

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings